LDR, a developer of implantable spine devices and instrumentation, has received the US Food and Drug Administration (FDA) approval for its ROI-A Oblique ALIF cage.
The ROI-A Oblique ALIF cage utilizes the company’s integrated VerteBRIDGE plating technology which reduces the need for additional anterior or posterior instrumentation.
The system features an inserter that protects anatomical structures while implanting the cage and plating.
The ROI-A Oblique system minimizes the mobilization of the anterior vessels, thus minimizing neurologic risks.
Through a direct anterolateral approach, the oblique cage and self-guided, curved VerteBRIDGE plating are delivered in the lumbar regions plane of the disc.